Aug. 25 at 4:31 PM
$PMN On August 20, 2026, Nature Reviews Chemistry published a peer-reviewed review, “Targeting soluble misfolded oligomers in anti-amyloid research.” The authors are academic researchers at the University of Southern Denmark and Kent State University; they declare no competing interests. The review states that increasing evidence points to soluble oligomers as the primary cytotoxic species in amyloid diseases and argues that future disease-modifying therapies will depend on selectively detecting and modulating specific toxic oligomeric states in vivo.
What matters for PMN310 is that this is not ProMIS commentary and not financial coverage. It independently reinforces the central biological proposition behind PMN310: plaques may be downstream deposits, while soluble Aβ oligomers can be the more directly toxic species.
